Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Cunningham D., Hawthorn J., Pople A., Gazet J. C., Ford H. T., Challoner T., Coombes R. C. Prevention of emesis in patients receiving cytotoxic drugs by GR38032F, a selective 5-HT3 receptor antagonist. Lancet. 1987 Jun 27;1(8548):1461–1463. doi: 10.1016/s0140-6736(87)92208-2. [DOI] [PubMed] [Google Scholar]
- Gralla R. J., Itri L. M., Pisko S. E., Squillante A. E., Kelsen D. P., Braun D. W., Jr, Bordin L. A., Braun T. J., Young C. W. Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting. N Engl J Med. 1981 Oct 15;305(16):905–909. doi: 10.1056/NEJM198110153051601. [DOI] [PubMed] [Google Scholar]
- Kilpatrick G. J., Jones B. J., Tyers M. B. Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding. Nature. 1987 Dec 24;330(6150):746–748. doi: 10.1038/330746a0. [DOI] [PubMed] [Google Scholar]
- Morrow G. R. Clinical characteristics associated with the development of anticipatory nausea and vomiting in cancer patients undergoing chemotherapy treatment. J Clin Oncol. 1984 Oct;2(10):1170–1176. doi: 10.1200/JCO.1984.2.10.1170. [DOI] [PubMed] [Google Scholar]
- Sallan S. E., Cronin C., Zelen M., Zinberg N. E. Antiemetics in patients receiving chemotherapy for cancer: a randomized comparison of delta-9-tetrahydrocannabinol and prochlorperazine. N Engl J Med. 1980 Jan 17;302(3):135–138. doi: 10.1056/NEJM198001173020302. [DOI] [PubMed] [Google Scholar]
- Seigel L. J., Longo D. L. The control of chemotherapy-induced emesis. Ann Intern Med. 1981 Sep;95(3):352–359. doi: 10.7326/0003-4819-95-3-352. [DOI] [PubMed] [Google Scholar]